Kay Hagan actually said...

How many of these are rare diseases? Is there any effort underway to expand the number of diseases we screen for? Why or why not?

One challenge that many of the witnesses today spoke of is the need to incentivize the device and drug/biotech industry to develop therapeut...

This committee has shown great leadership on this issue in the past, and I am committed to seeing it continue to ensure progress continues f...

I, too, believe that helping every American child reach their full potential is one of the most important things that we, as public official...